BAGGIO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.430
AS - Asia 3.204
EU - Europa 2.482
AF - Africa 991
SA - Sud America 746
OC - Oceania 121
Continente sconosciuto - Info sul continente non disponibili 53
Totale 18.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.963
SG - Singapore 1.039
HK - Hong Kong 568
CN - Cina 494
BR - Brasile 437
FI - Finlandia 289
DE - Germania 282
UA - Ucraina 271
SE - Svezia 211
PL - Polonia 170
VN - Vietnam 169
FR - Francia 165
IT - Italia 116
RU - Federazione Russa 100
GB - Regno Unito 97
AR - Argentina 50
IE - Irlanda 46
TR - Turchia 46
EC - Ecuador 44
MX - Messico 44
IN - India 41
AE - Emirati Arabi Uniti 39
ZA - Sudafrica 38
NL - Olanda 37
SA - Arabia Saudita 37
LV - Lettonia 35
PA - Panama 35
VE - Venezuela 35
AO - Angola 34
RS - Serbia 34
UZ - Uzbekistan 34
BY - Bielorussia 33
ES - Italia 33
GM - Gambi 33
PE - Perù 33
CI - Costa d'Avorio 32
IS - Islanda 32
LA - Repubblica Popolare Democratica del Laos 32
MN - Mongolia 32
SI - Slovenia 32
BA - Bosnia-Erzegovina 31
DZ - Algeria 31
IL - Israele 31
MD - Moldavia 31
BW - Botswana 30
MR - Mauritania 30
NC - Nuova Caledonia 30
PH - Filippine 30
PK - Pakistan 30
PS - Palestinian Territory 30
PY - Paraguay 30
RE - Reunion 30
YT - Mayotte 30
AT - Austria 29
AU - Australia 29
CL - Cile 29
HU - Ungheria 29
KE - Kenya 29
KG - Kirghizistan 29
ZM - Zambia 29
CZ - Repubblica Ceca 28
IQ - Iraq 28
KZ - Kazakistan 28
MU - Mauritius 28
SO - Somalia 28
TH - Thailandia 28
XK - ???statistics.table.value.countryCode.XK??? 28
BE - Belgio 27
KH - Cambogia 27
ML - Mali 27
AF - Afghanistan, Repubblica islamica di 26
BB - Barbados 26
CG - Congo 26
CH - Svizzera 26
CO - Colombia 26
HN - Honduras 26
ID - Indonesia 26
JM - Giamaica 26
JO - Giordania 26
MK - Macedonia 26
TT - Trinidad e Tobago 26
BF - Burkina Faso 25
BZ - Belize 25
DJ - Gibuti 25
GN - Guinea 25
NP - Nepal 25
TZ - Tanzania 25
UG - Uganda 25
CU - Cuba 24
DK - Danimarca 24
EG - Egitto 24
ET - Etiopia 24
MA - Marocco 24
ME - Montenegro 24
NZ - Nuova Zelanda 24
TJ - Tagikistan 24
TW - Taiwan 24
GH - Ghana 23
GT - Guatemala 23
JP - Giappone 23
Totale 16.912
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.362
Fairfield 1.036
Jacksonville 914
Ann Arbor 907
Houston 861
Chandler 742
Singapore 652
Ashburn 633
Hong Kong 543
Wilmington 427
Princeton 358
Seattle 352
Cambridge 351
Boardman 262
Bytom 136
Santa Clara 126
Beijing 112
San Diego 100
Nanjing 96
Des Moines 95
Dong Ket 94
Helsinki 91
Roxbury 89
Medford 72
Los Angeles 46
Guangzhou 38
Hebei 37
Dublin 35
Norwalk 31
Ulan Bator 31
Abidjan 30
Panama City 30
Luanda 29
Lusaka 29
Nanchang 29
Noumea 29
Riga 29
Tashkent 29
Nouakchott 28
Vientiane 28
Bishkek 27
Munich 27
Amman 26
Bamako 26
Phnom Penh 26
Reykjavik 26
São Paulo 26
Kampala 25
Minsk 25
Nairobi 25
Conakry 24
Dushanbe 24
Ho Chi Minh City 24
Jiaxing 24
Bridgetown 23
Chicago 23
Kigali 23
Vienna 23
Dakar 22
Dili 22
Harare 22
Havana 22
Lima 22
Ouagadougou 22
Accra 21
Baku 21
Banjul 21
Libreville 21
New York 21
Shenyang 21
Andorra la Vella 20
Djibouti 20
Hanoi 20
Kingstown 20
Pristina 20
Antananarivo 19
Cayenne 19
Gaborone 19
Nassau 19
Niamey 19
Tel Aviv 19
Yerevan 19
Addis Ababa 18
Auckland 18
Dar es Salaam 18
Mamoudzou 18
Managua 18
Montevideo 18
Belgrade 17
Chisinau 17
Praia 17
San José 17
Brazzaville 16
Castries 16
Kuala Lumpur 16
Quito 16
Changsha 15
Guayaquil 15
Kingston 15
London 15
Totale 12.157
Salva come PNG Salva come JPEG
Nome #
ABNORMAL URATE TRANSPORT IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM NEPHROLITHIASIS - A POSSIBLE LINK WITH HYPERURICOSURIA 191
Mesangial cell proliferation in long-term streptozotocin-induced diabetes mellitus in the rat and the renoprotective activity of heparin 186
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 185
Functional correlation between the Ser/Thr-phosphorylation of band-3 and band-3-mediated transmembrane anion transport in human erythrocytes 178
Abnormal erythrocyte charge in diabetes mellitus: link with microalbuminuria. 172
Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro. 171
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients 170
Renal impairment in chronic cigarette smokers. 167
Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis 164
ACE INHIBITORS IN RENAL-DISEASE 163
An inheritable anomaly in red-cell oxalate transport in ''primary'' calcium nephrolithiasis correctable with diuretics. 161
Arachidonic acid-induced IL-6 expression is mediated by PKCalpha activation in osteoblastic cells 161
DIFFERENT HEPARIN DOSAGES ARE NEEDED TO AMELIORATE THE EVOLUTION OF DIFFERENT EXPERIMENTAL NEPHROPATHIES - DOES THIS MEAN DIFFERENT HEPARIN TARGETS 159
Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). 159
Tyrosine-protein kinase inhibition in human erythrocytes by polyphosphoinositides (PIP and PIP2) 159
In vivo activation of renal phospholipase activity by bradykinin in the rat. 158
Digitalis and the renin-angiotensin axis in congestive heart failure. 158
Pathogenesis of idiopathic calcium nephrolithiasis: Update 1997 157
Acquisizione del fenotipo miofibroblastico e transizione epItelio mesenchima in colture primarie di cellule renali umane. 157
Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. 157
An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics. 156
Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid 155
Relationship Between Membrane-protein Phosphorylation and Intracellular Translocation of Casein Kinase In Human Erythrocytes 155
DIALYSIS-RELATED AMYLOIDOSIS 151
Molecular biology of diabetic glomerulosclerosis 151
EFFECT OF ALKALINE CITRATE THERAPY ON CLEARANCE OF RESIDUAL RENAL STONE FRAGMENTS AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY IN STERILE CALCIUM AND INFECTION NEPHROLITHIASIS PATIENTS 144
THERAPY WITH GLYCOSAMINOGLYCANS IN NEPHROLOGY 143
VERY EARLY NUTRITION SUPPLEMENTATION IN BURNED PATIENTS 142
A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens 142
Patterns of renal injury in NIDDM patients with microalbuminuria 137
Abnormal urate transport in erythrocytes of idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria. 136
GLYCOSAMINOGLYCAN CONTENT, OXALATE SELF-EXCHANGE AND PROTEIN-PHOSPHORYLATION IN ERYTHROCYTES OF PATIENTS WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 133
Relation between band 3 red blood cell protein and transmembrane oxalate flux in stone formers. 133
Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis. 133
ANTIPROTEINURIC EFFECT OF GLYCOSAMINOGLYCANS 132
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. 132
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 130
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 130
Phosphorylation of Band-3 Protein In Nephrolithiasis 130
Von Willebrand factor abnormalities in IgA nephropathy. 127
Kidney kallikrein and phospholipase activities in Milan spontaneously hypertensive rats. 126
EFFECTS OF THE ORAL-ADMINISTRATION OF GLYCOSAMINOGLYCANS ON CELLULAR ABNORMALITIES ASSOCIATED WITH IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS 125
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR COLLAGEN-IV-ALPHA-1 AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 125
DIET AND NEPHROLITHIASIS - STUDY IN AN OBESE POPULATION 124
Arachidonic acid and its metabolites prostaglandin 1 and 2 increase intracellular calcium in cultured human osteoblast-like MG63 cells. 123
Glycosaminoglycans: A new paradigm in the prevention of proteinuria and progression of glomerular disease 121
ERYTHROCYTE URATE SELF EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 120
Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression 120
Protein diet and hypercalciuria 119
Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis 119
EFFECT OF HEPARIN TREATMENT ON GLOMERULAR-ALPHA-1-(IV)-COLLAGEN AND TGF-BETA-1 EXPRESSION AND DEPOSITION IN DIABETIC RATS 119
Experimental peritoneal fibrosis: Favorable effects of glycosaminoglycans (GAGS) 118
Cardiovascular risk factors, smoking and kidney function 115
Genetic approach to the study of cellular ion transport anomalies in idiopathic calcium nephrolithiasis 115
CORRECTION OF ERYTHROCYTE ABNORMALITIES IN IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS AND REDUCTION OF URINARY OXALATE BY ORAL GLYCOSAMINOGLYCANS 114
Isolation and properties of a protein kinase from rat liver microsomes. 114
Urinary angiotensin-I-converting enzyme activity as a marker of tubulo-interstitial involvement in kidney diseases. 113
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 113
Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis 113
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 113
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis 112
Ischemic renal disease: impact of cardiovascular risk factors and smoking 110
Diagnostic and therapeutic approach in patients with urinary calculi 110
Altered Red-blood-cell Membrane-protein Phosphorylation In Idiopathic Calcium-oxalate Nephrolithiasis 110
ROLE OF GLYCOSAMINOGLYCANS IN DIABETIC NEPHROPATHY 110
MOLECULAR PATHOGENESIS OF MEMBRANOUS NEPHROPATHY 110
Erythrocyte membrane protein phosphorylation in urolithiasis. 110
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 109
Vascular endothelial growth factor expression in microdissected glomeruli of type 2 diabetic patients. 108
Treatment with glycosaminoglycans of renal diseases related problems. 107
Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. 107
Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insorgence of calcium lithogenesis 107
Band 3 tyr-phosphorylation in normal and glucose-6-dehydrogenase-defcient huamn erythrocytes 107
Specific modulatory effect of arachidonic acid on bone cytokine mRNA expression 106
Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinoger and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA) 105
Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. 105
ERYTHROCYTE URATE SELF-EXCHANGE IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 105
Oral glycosaminoglycans (GAGs) ameliorate peritoneal transport in CAPD patients. 104
Ultrastructural measures of glomerular extracellular matrix accumulation in non-proteinuric type 2 diabetic patients. 103
Eicosapentaenoic acid modulates CyA-induced proinflammatory cytokine over-expression in osteoblastic cells in vitro 102
Renal structure incaucasian noninsulindependent diabetic patients. 101
Growth factors and the kidney in diabetes mellitus. 101
[Investigation of antibodies adhering to bacteria in children with vesico-ureteral reflux] 100
Fatty acids and idiopathic calcium nephrolithiasis 100
Arachidonic acid influences intracellular calcium handling in human osteoblasts 100
Use of glycosaminoglycans to increase efficiency long-term continuous peritoneal dialysis. 100
Renal function in the elderly: is the decline inevitable? 98
ANOMALOUS ARACHIDONIC-ACID METABOLISM IN IDIOPATHIC CALCIUM NEPHROLITHIASIS 97
TGF-beta 1 renal overexpression in diabetic rats and in high glucose mesangial cell cultures: Inhibition by heparinoids. 96
EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells. 95
Mechanism of oxalate cellular transport in idiopathic calcium nephrolithiasis 95
Glicosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats 94
Calcium nephrolithiasis - A systemic disease 94
Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis. 94
Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis? 93
Nutrition and calcium nephrolithiasis: The lipid hypothesis 92
Quantitative and qualitative changes in VEGF gene expression in glomeruli of patients with type 2 diabetes. 92
Heparin reduces the glomerular infiltration by macrophages and modulates macrophage TGF beta and latent TGF beta binding protein synthesis in chronic puromycin glomerulosclerosis 92
IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS - A CELLULAR-DISEASE 90
ERYTHROCYTE FLUXES AND RENAL HANDLING OF OXALATE AND URATE IN CALCIUM OXALATE NEPHROLITHIASIS 90
Totale 12.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.575
article - articoli 48.346
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 255
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.209
Totale 107.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.231 0 0 0 125 51 186 36 134 255 80 205 159
2021/20221.639 20 255 90 162 112 85 22 168 114 24 193 394
2022/20231.567 364 141 10 167 314 246 1 89 154 6 52 23
2023/2024630 26 82 64 48 34 40 21 123 12 3 91 86
2024/20252.825 4 220 199 108 414 32 100 180 237 101 474 756
2025/20264.424 276 1.043 1.697 1.408 0 0 0 0 0 0 0 0
Totale 18.056